The role of HOPX in normal tissues and tumor progression

• Published in: Bioscience reports Vol. 40; no. 1
• Main Authors: Liu, Yijun, Zhang, Wenling
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd 31-01-2020
• Subjects: Animals; Cancer; Cell Differentiation - physiology; Cell Migration, Adhesion & Morphology; Diagnostics & Biomarkers; Disease Progression; DNA Methylation - physiology; Homeodomain Proteins - metabolism; Humans; Neoplasms - metabolism; Neoplasms - pathology; Review; Serum Response Factor - metabolism; Tumor Suppressor Proteins - metabolism; methylation; tumour; HOPX; tumor suppressor gene; normal tissues
• ISSN: 0144-8463; 1573-4935
• DOI: 10.1042/bsr20191953

The homeodomain-only protein homeobox (HOPX) as the smallest homeodomain protein, lacks certain conserved residues required for DNA binding. Through our literature search, we reviewed the current understandings of HOPX in normal tissues and tumor progression. HOPX was initially identified as a critical transcription factor in various normal tissues, which interacted with serum response factor (SRF) or other substance to regulate normal physiological function. However, HOPX is at a low expression or methylation level in tumors. These data indicated that HOPX may play a very important role in regulating differentiation phenotype and tumor suppressive function. We predicted the prognosis of HOPX in tumors from TCGA database and discussed the downstream genes of HOPX. To understand how HOPX is involved in the mechanisms between physical and pathological conditions could lead to novel therapeutic strategies for treatment.